West Pharmaceutical Services Retained Earnings (Accumulated Deficit) 2010-2024 | WST

West Pharmaceutical Services retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  • West Pharmaceutical Services retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $3.857B, a 12.91% increase year-over-year.
  • West Pharmaceutical Services retained earnings (accumulated deficit) for 2023 were $3.523B, a 17.93% increase from 2022.
  • West Pharmaceutical Services retained earnings (accumulated deficit) for 2022 were $2.988B, a 21.62% increase from 2021.
  • West Pharmaceutical Services retained earnings (accumulated deficit) for 2021 were $2.457B, a 33.03% increase from 2020.
West Pharmaceutical Services Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $3,523
2022 $2,988
2021 $2,457
2020 $1,847
2019 $1,549
2018 $1,353
2017 $1,178
2016 $1,072
2015 $965
2014 $902
2013 $805
2012 $720
2011 $665
2010 $613
2009 $569
West Pharmaceutical Services Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $3,857
2024-06-30 $3,721
2024-03-31 $3,624
2023-12-31 $3,523
2023-09-30 $3,416
2023-06-30 $3,255
2023-03-31 $3,114
2022-12-31 $2,988
2022-09-30 $2,913
2022-06-30 $2,793
2022-03-31 $2,617
2021-12-31 $2,457
2021-09-30 $2,336
2021-06-30 $2,160
2021-03-31 $1,985
2020-12-31 $1,847
2020-09-30 $1,773
2020-06-30 $1,703
2020-03-31 $1,612
2019-12-31 $1,549
2019-09-30 $1,497
2019-06-30 $1,453
2019-03-31 $1,398
2018-12-31 $1,353
2018-09-30 $1,313
2018-06-30 $1,258
2018-03-31 $1,223
2017-12-31 $1,178
2017-09-30 $1,189
2017-06-30 $1,148
2017-03-31 $1,119
2016-12-31 $1,072
2016-09-30 $1,042
2016-06-30 $1,014
2016-03-31 $978
2015-12-31 $965
2015-09-30 $940
2015-06-30 $947
2015-03-31 $927
2014-12-31 $902
2014-09-30 $879
2014-06-30 $856
2014-03-31 $825
2013-12-31 $805
2013-09-30 $789
2013-06-30 $775
2013-03-31 $745
2012-12-31 $720
2012-09-30 $712
2012-06-30 $697
2012-03-31 $688
2011-12-31 $665
2011-09-30 $658
2011-06-30 $641
2011-03-31 $627
2010-12-31 $613
2010-09-30 $618
2010-06-30 $600
2010-03-31 $584
2009-12-31 $569
2009-09-30 $560
2009-06-30 $542
2009-03-31 $528
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.239B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49